Amount Raised
$110 Million
Round Type
Series B
CambridgeOtherBiotechnologyHealth CareTherapeuticsDescription
Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced it has raised $110 million in a Series B financing. Proceeds will advance the company’s lead candidate VOR33 into clinical trials, deepen its portfolio, and accelerate the validation of additional targets for its scientific platform, which is designed to remove redundant proteins so that transplanted stem cells become invisible to targeted therapies while leaving diseased cells vulnerable. Vor’s treatment strategy has the potential to bring a revolutionary treatment paradigm for patients with acute myeloid leukemia and other hematologic malignancies.
Quick answer
Vor Bio raised $110 Million in a Series B round, dated July 7, 2020. Vor Bio is based in Cambridge, Massachusetts, United States.
- How much did Vor Bio raise?
- Vor Bio raised $110 Million in a Series B round on July 7, 2020.
- What does Vor Bio do?
- Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases.
- Where is Vor Bio based and how big is it?
- Vor Bio is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Vor Bio?
- Fundz holds 2 contacts at Vor Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Vor Bio that raised within 45 days of this round, from Fundz verified event records.
- Cartesian Therapeutics, Inc. raised $25M on August 18, 2020.
- Jade Biosciences raised $76M on August 14, 2020.
- Dyne Therapeutics raised $116M on August 14, 2020.
- Vaccinex raised $8M on August 11, 2020.
- Korsana Biosciences raised $24M on August 11, 2020.
- Biohaven raised $450M (Funding Round) on August 7, 2020.
Who to call at Vor Bio, and when
A new round usually means Vor Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vor Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vor Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vor Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vor Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVor Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.